1818-0876

Asian Journal of Pharmaceutical Sciences

Elsevier

View prefix report (10.1016)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 985 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact985 DOIs
2

Attach ORCID iDs across 680 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact680 DOIs
3

Deposit reference lists for 20 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact20 DOIs

DOIs for this ISSN

Showing the top 5 of 985 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 A review on phospholipids and their main applications in dru… (10.1016/j.ajps.2014.09.004)
Abstract ORCID
141.04 661
2 Bioactive flavonoids in medicinal plants: Structure, activit… (10.1016/j.ajps.2017.08.004)
Abstract ORCID
140.94 658
3 Pharmaceutical particle technologies: An approach to improve… (10.1016/j.ajps.2014.05.005)
Abstract ORCID
138.39 585
4 Alginate and alginate composites for biomedical applications (10.1016/j.ajps.2020.10.001)
Abstract ORCID
131.37 423
5 The endocytosis and intracellular fate of nanomedicines: Imp… (10.1016/j.ajps.2013.07.001)
Abstract ORCID
128.11 364
6 Studies on thermoresponsive polymers: Phase behaviour, drug… (10.1016/j.ajps.2014.08.010)
Abstract ORCID
128.11 364
7 Thin films as an emerging platform for drug delivery (10.1016/j.ajps.2016.05.004)
Abstract ORCID
127.69 357
8 Development of 3D bioprinting: From printing methods to biom… (10.1016/j.ajps.2019.11.003)
Abstract ORCID
126.76 342
9 Nanocrystals for enhancement of oral bioavailability of poor… (10.1016/j.ajps.2014.08.005)
Abstract ORCID
123.64 296
10 Overview of milling techniques for improving the solubility… (10.1016/j.ajps.2014.12.006)
Abstract ORCID
123.27 291
11 Effect of process and formulation variables on the preparati… (10.1016/j.ajps.2015.09.004)
Abstract ORCID
122.59 282
12 Plant-derived exosome-like nanoparticles and their therapeut… (10.1016/j.ajps.2021.05.006)
Abstract ORCID
121.97 274
13 A practical guide to pharmaceutical polymorph screening &amp… (10.1016/j.ajps.2014.05.002)
Abstract ORCID
116.52 213
14 Recent trends on wound management: New therapeutic choices b… (10.1016/j.ajps.2019.11.008)
Abstract ORCID
114.50 194
15 Film forming systems for topical and transdermal drug delive… (10.1016/j.ajps.2017.07.004)
Abstract ORCID
114.28 192
16 Near-infrared light-responsive inorganic nanomaterials for p… (10.1016/j.ajps.2015.11.123)
Abstract ORCID
112.64 178
17 Chlorogenic acid loaded chitosan nanoparticles with sustaine… (10.1016/j.ajps.2014.09.005)
Abstract ORCID
111.65 170
18 Size, shape, charge and “stealthy” surface: Carrier properti… (10.1016/j.ajps.2020.07.005)
Abstract ORCID
111.52 169
19 ROS-responsive drug delivery systems for biomedical applicat… (10.1016/j.ajps.2017.11.002)
Abstract ORCID
110.87 164
20 pH-sensitive polymeric micelles triggered drug release for e… (10.1016/j.ajps.2013.07.021)
Abstract ORCID
110.61 162
21 Application of quality by design in the current drug develop… (10.1016/j.ajps.2016.07.006)
Abstract ORCID
108.66 148
22 Development of liposomal formulations: From concept to clini… (10.1016/j.ajps.2013.07.010)
Abstract ORCID
108.07 144
23 Delivery systems for siRNA drug development in cancer therap… (10.1016/j.ajps.2014.08.011)
Abstract ORCID
108.07 144
24 Intranasal administration of carbamazepine-loaded carboxymet… (10.1016/j.ajps.2017.09.001)
Abstract ORCID
107.31 139
25 Tumor microenvironment responsive drug delivery systems (10.1016/j.ajps.2019.08.003)
Abstract ORCID
107.31 139
26 Electrospun nanofibers as a wound dressing for treating diab… (10.1016/j.ajps.2018.04.004)
Abstract ORCID
107.15 138
27 In situ forming hydrogels based on chitosan for drug deliver… (10.1016/j.ajps.2016.07.001)
Abstract ORCID
106.52 134
28 Nanocarriers as a powerful vehicle to overcome blood-brain b… (10.1016/j.ajps.2018.09.005)
Abstract ORCID
106.19 132
29 The solute carrier transporters and the brain: Physiological… (10.1016/j.ajps.2019.09.002)
Abstract ORCID
104.50 122
30 Current update on nanoplatforms as therapeutic and diagnosti… (10.1016/j.ajps.2020.03.003)
Abstract ORCID
104.50 122
31 Developments of mucus penetrating nanoparticles (10.1016/j.ajps.2014.12.007)
Abstract ORCID
104.14 120
32 Preparation of 5-fluorouracil-loaded chitosan nanoparticles… (10.1016/j.ajps.2017.04.002)
Abstract ORCID
103.59 117
33 Insights into the swelling process and drug release mechanis… (10.1016/j.ajps.2013.12.002)
Abstract ORCID
103.03 114
34 Redox dual-stimuli responsive drug delivery systems for impr… (10.1016/j.ajps.2019.06.003)
Abstract ORCID
101.67 107
35 Engineered targeting tLyp-1 exosomes as gene therapy vectors… (10.1016/j.ajps.2019.04.002)
Abstract ORCID
100.43 101
36 Progress involving new techniques for liposome preparation (10.1016/j.ajps.2014.06.001)
Abstract ORCID
100.00 99
37 Liposomes as sterile preparations and limitations of sterili… (10.1016/j.ajps.2013.07.011)
Abstract ORCID
99.56 97
38 Nanopreparations for mitochondria targeting drug delivery sy… (10.1016/j.ajps.2017.05.006)
Abstract ORCID
99.34 96
39 External-stimuli responsive systems for cancer theranostic (10.1016/j.ajps.2016.06.001)
Abstract ORCID
98.89 94
40 Nanotechnology and vaccine development (10.1016/j.ajps.2014.06.002)
Abstract ORCID
98.66 93
41 Development of tacrolimus-loaded transfersomes for deeper sk… (10.1016/j.ajps.2013.09.005)
Abstract ORCID
98.19 91
42 Applications and developments of gene therapy drug delivery… (10.1016/j.ajps.2021.05.003)
Abstract ORCID
97.22 87
43 Organogels, hydrogels and bigels as transdermal delivery sys… (10.1016/j.ajps.2013.07.006)
Abstract ORCID
96.98 86
44 Development of polyurethane foam dressing containing silver… (10.1016/j.ajps.2018.09.001)
Abstract ORCID
96.47 84
45 Advances in the development of amorphous solid dispersions:… (10.1016/j.ajps.2023.100834)
Abstract ORCID
96.47 84
46 Extrusion–spheronization a promising pelletization technique… (10.1016/j.ajps.2016.08.001)
Abstract ORCID
95.95 82
47 Nanomedicine potentiates mild photothermal therapy for tumor… (10.1016/j.ajps.2021.10.001)
Abstract ORCID
95.95 82
48 Cellulose based polymers in development of amorphous solid d… (10.1016/j.ajps.2018.09.003)
Abstract ORCID
95.69 81
49 Novel chemical permeation enhancers for transdermal drug del… (10.1016/j.ajps.2014.01.001)
Abstract ORCID
95.15 79
50 Drug-drug cocrystals: Opportunities and challenges (10.1016/j.ajps.2020.06.004)
Abstract ORCID
94.88 78